Showing 41 to 60 of 80 bills
| Bill Title | Introduced | Latest Action |
|---|---|---|
|
HB 1470
(Pennsylvania - 2025-2026 Regular Session)
An Act amending the act of June 13, 1967 (P.L.31, No.21), known as the Human Services Code, in public assistance, providing for subscription model for GLP-1 agonists. |
May 15 2025 |
Referred To Human Services
May 15 2025 |
|
HB 2677
(Texas - 89th Legislature (2025))
Relating to Medicaid coverage and reimbursement for the treatment of obesity and certain diabetes prevention program services. |
Feb 11 2025 |
Placed On General State Calendar
May 14 2025 |
|
HB 1332
(Arkansas - 2025 Regular Session)
To Require The Arkansas Medicaid Program To Evaluate Claims For Diagnoses Frequency Of Obesity-Related Conditions And Present The Costs. |
Jan 30 2025 |
Died In Senate Committee At Sine Die Adjournment.
May 05 2025 |
|
HB 1971
(Washington - 2025-2026 Regular Session)
Increasing access to prescription hormone therapy. |
Feb 13 2025 |
Effective Date 7/27/2025.
Apr 25 2025 |
|
LD 627
(Maine - 132nd Legislature (2025-2026))
An Act To Require Insurance Coverage For Glucagon-Like Peptide-1 Receptor Agonist Medication |
Feb 20 2025 |
Pursuant To Joint Rule 310.3 Placed In Legislative Files (Dead)
Apr 08 2025 |
|
HF 701
(Iowa - 2025-2026 Regular Session)
A bill for an act relating to a review of anti-obesity medications by the department of health and human services for purposes of the medical assistance program. |
Feb 28 2025 |
Referred To Health And Human Services.
Apr 03 2025 |
|
SB 2729
(Texas - 89th Legislature (2025))
Relating to Medicaid coverage and reimbursement for the treatment of obesity and certain diabetes prevention program services. |
Mar 13 2025 |
Referred To Health & Human Services
Apr 03 2025 |
|
HB 2412
(Texas - 89th Legislature (2025))
Relating to health benefit plan coverage for certain obesity medications. |
Feb 04 2025 |
Referred To Insurance
Mar 17 2025 |
|
SB 271
(Pennsylvania - 2025-2026 Regular Session)
An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage for anti-obesity treatments; and abrogating a regulation. |
Feb 20 2025 |
Referred To Banking & Insurance
Feb 20 2025 |
|
HB 1430
(Mississippi - 2025 Regular Session)
Prescription drugs; prohibit licensing boards from prohibiting practitioners from prescribing for off-label use. |
Jan 20 2025 |
Died On Calendar
Feb 13 2025 |
|
HB 5485
(Connecticut - 2025 Regular Session)
An Act Establishing A Captive Insurance Company To Administer A Bulk Purchase And Distribution Of Glucagon-Like Peptide-1 Prescription Drugs To Qualifying Individuals In This State To Treat Obesity. |
Jan 17 2025 |
Ref. To Joint Comm. On Insurance And Real Estate
Jan 17 2025 |
|
SB 860
(Illinois - 103rd Regular Session)
State Government-Tech |
Feb 02 2023 |
Public Act . . . . . . . . . 103-0890
Aug 09 2024 |
|
H 4910
(Massachusetts - 193rd Legislature (2023-2024))
Amendment H.4910 |
Jul 24 2024 |
H4891, Published As Amended
Jul 24 2024 |
|
HB 2702
(Missouri - 2024 Regular Session)
Provides for MO HealthNet coverage of anti-obesity medications |
Feb 14 2024 |
Referred: General Laws(H)
May 17 2024 |
|
SB 24-054
(Colorado - 2024 Regular Session)
Diabetes Prevention & Obesity Treatment Act |
Jan 17 2024 |
House Committee On Appropriations Lay Over Unamended - Amendment(S) Failed
May 14 2024 |
|
SB 674
(Tennessee - 113th Regular Session (2023-2024))
Health Care - As introduced, permits the services authorized in a collaborative pharmacy practice agreement to include weight management services; requires the bureau of TennCare to make available, or cause to be made available, anti-obesity medication to a recipient if the medication is medically necessary. - Amends TCA Title 63, Chapter 10 and Title 71, Chapter 5. |
Jan 26 2023 |
Assigned To General Subcommittee Of Senate Finance, Ways, And Means Committee
Apr 23 2024 |
|
S 8959
(New York - 2023 Regular Session)
Requires comprehensive coverage for treatment of obesity |
Apr 03 2024 |
Referred To Health
Apr 03 2024 |
|
HB 2
(Utah - 2024 General Session)
New Fiscal Year Supplemental Appropriations Act |
Feb 25 2024 |
Governor Line Item Veto
Mar 21 2024 |
|
SB 743
(West Virginia - 2024 Regular Session)
Relating to Bureau for Medical Services’ medically supervised weight loss program |
Feb 09 2024 |
Referred To Finance On 2nd Reading
Feb 21 2024 |
|
S 2554
(New Jersey - 2024-2025 Regular Session)
Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications. |
Feb 08 2024 |
Introduced In The Senate, Referred To Senate Health, Human Services And Senior Citizens Committee
Feb 08 2024 |
Showing 41 to 60 of 80 bills
